Cargando…

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated death worldwide. Angiogenesis, the process of formation of new blood vessels, is required for cancer cells to obtain nutrients and oxygen. HCC is a typical hypervascular solid tumor with an aberrant vascular network and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Changyu, Wu, Shilun, Kong, Jian, Sun, Yiwen, Bai, Yannan, Zhu, Ruhang, Li, Zhuxin, Sun, Wenbing, Zheng, Lemin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843448/ https://www.ncbi.nlm.nih.gov/pubmed/36647777 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0449

Ejemplares similares

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy
por: Kong, Jian, et al.
Publicado: (2020)

Platelet lysates in Hepatocellular Carcinoma patients after radiofrequency ablation facilitate tumor proliferation, invasion and vasculogenic mimicry
por: Jia, Guoqun, et al.
Publicado: (2020)

After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma
por: Kong, Jian, et al.
Publicado: (2012)

Circular BANP knockdown inhibits the malignant progression of residual hepatocellular carcinoma after insufficient radiofrequency ablation
por: Li, Guoming, et al.
Publicado: (2022)

Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA
por: Kong, Jian, et al.
Publicado: (2012)

YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma
por: Kong, Jian, et al.
Publicado: (2014)

Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation
por: Dong, Shuying, et al.
Publicado: (2015)

Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways
por: Dong, Shuying, et al.
Publicado: (2013)

Complications of Radiofrequency Ablation for Hepatic Hemangioma: A Multicenter Retrospective Analysis on 291 Cases
por: Wu, Shilun, et al.
Publicado: (2021)

Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation
por: Zhang, Qingyun, et al.
Publicado: (2017)

ICAM‐1 Activates Platelets and Promotes Endothelial Permeability through VE‐Cadherin after Insufficient Radiofrequency Ablation
por: Kong, Jian, et al.
Publicado: (2021)

Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
por: Pircher, Andreas, et al.
Publicado: (2011)

Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017)

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020)

FOXK2 downregulation suppresses EMT in hepatocellular carcinoma
por: Kong, Jian, et al.
Publicado: (2020)

Tumor angiogenesis and anti-angiogenic gene therapy for cancer
por: Li, Tinglu, et al.
Publicado: (2018)

Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
por: Teleanu, Raluca Ioana, et al.
Publicado: (2019)

Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis
por: Chung, Monica S., et al.
Publicado: (2022)

Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
por: Li, Xiaomi, et al.
Publicado: (2022)

Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma
por: Barbhuiya, Mustafa A., et al.
Publicado: (2017)

Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma
por: Jiang, Honglei, et al.
Publicado: (2017)

Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
por: Ioannidou, Evangelia, et al.
Publicado: (2021)

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
por: Plate, Karl H., et al.
Publicado: (2012)

Extracellular vesicles in tumor angiogenesis and resistance to anti‐angiogenic therapy
por: Ye, Zi‐Wu, et al.
Publicado: (2023)

Anti-angiogenic and anti-proliferative effects of Benja-ummarit extract in rats with hepatocellular carcinoma
por: Kaewnoonual, Nattpawit, et al.
Publicado: (2020)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
por: Joo, Yu Young, et al.
Publicado: (2019)

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
por: Kasprzak, Aldona, et al.
Publicado: (2018)

Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer
por: Li, Yingying, et al.
Publicado: (2022)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies
por: Yin, Lei, et al.
Publicado: (2020)

Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis
por: Dong, Xue, et al.
Publicado: (2021)

Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
por: Gao, Xiaoge, et al.
Publicado: (2023)

Response to immunotherapy plus anti‐angiogenic agent combination challenges hepatocellular carcinoma prognostic scores
por: Adhoute, Xavier, et al.
Publicado: (2022)

Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity
por: Gao, Xiaoge, et al.
Publicado: (2023)

The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer
por: Liu, Junxia, et al.
Publicado: (2022)

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
por: Zhang, Feng, et al.
Publicado: (2014)

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
por: Korhonen, Ani, et al.
Publicado: (2021)

Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes
por: Zhang, Zhihao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7ao0s617c22frg3k2i7lm1bfg8